Home › Funds › DELTA ASSET MANAGEMENT LLC/TN › ABT

DELTA ASSET MANAGEMENT LLC/TN position in ABT

ABBOTT LABORATORIES · Health Care

DELTA ASSET MANAGEMENT LLC/TN reported holding 30,846 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$3.0M, representing 0.27% of its reported portfolio and ranking #45 among its reported holdings. DELTA ASSET MANAGEMENT LLC/TN has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)30.85K sh
Reported value held$3.05M
Portfolio Weight0.27%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How DELTA ASSET MANAGEMENT LLC/TN's ABT position evolved

DELTA ASSET MANAGEMENT LLC/TN first disclosed a stake in ABT in Q3 2023 at 35,856 shares (US$3.5M). The position peaked in Q2 2025 at 29,745 shares, worth US$4.0M. Across 13 filings, DELTA ASSET MANAGEMENT LLC/TN increased the stake 2 time(s), trimmed it 8 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 30,846 shares valued at US$3.0M — an increase of 298 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 35.86K $3.47M New
Q4 2023 34.72K $3.82M Reduce
Q1 2024 34.81K $3.96M Hold
Q2 2024 33.88K $3.52M Reduce
Q3 2024 32.45K $3.70M Reduce
Q4 2024 31.42K $3.55M Reduce
Q1 2025 30.30K $4.02M Reduce
Q2 2025 29.75K $4.05M Reduce
Q3 2025 29.71K $3.98M Hold
Q4 2025 29.09K $3.65M Reduce
Q1 2026 28.95K $2.97M Reduce
Q2 2026 30.55K $2.77M Add
Q3 2026 30.85K $3.05M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 21 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has DELTA ASSET MANAGEMENT LLC/TN held ABT?

DELTA ASSET MANAGEMENT LLC/TN has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is DELTA ASSET MANAGEMENT LLC/TN's current position in ABT?

As of Q3 2026, DELTA ASSET MANAGEMENT LLC/TN holds 30.85K shares of ABT (ABBOTT LABORATORIES), valued at $3.05M, representing 0.27% of its reported portfolio and ranking #45.

Has DELTA ASSET MANAGEMENT LLC/TN been buying or selling ABT?

In the latest 13F filing (Q3 2026), DELTA ASSET MANAGEMENT LLC/TN increased its position in ABT. The position peaked in Q2 2025 at 29.75K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.